Skip to content
★ Sign in to follow
BD
Insider activity · 24 months0 buys12 salesCumulative net flow
Total declarations
13
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (12 ops.)
€719k

Latest filing published 06 Feb 2026 for GeneDx Holdings Corp., €101k.

Filing timeline

BuySale
Bryan Dechairo

Insider track record

Disclosed buys
0
Disclosed sells
12
Signal history

Bryan Dechairo: trading record in brief

Bryan Dechairo appears in our data through filings on GeneDx Holdings Corp. shares, published by SEC (Form 4). Between 1 February 2026 and 4 February 2026, the trades on record add up to 13 filings.

The open-market record consists of 12 sales worth €719k, with no purchase. Other entries cover 1 option exercise.

The latest filing, published on 6 February 2026, reports an open-market sale of €101k in GeneDx Holdings Corp. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Bryan Dechairo

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total
  • ▼
    Chief Operating OfficerExecutivesGeneDx Holdings Corp.
    119,458 USD27SEC
    1,425 shares@ US$83.8314.1% of flowClass A Common StockSEC:0002051759-26-000008:1
  • ▼
    Chief Operating OfficerExecutivesGeneDx Holdings Corp.
    87,818 USD27SEC
    1,034 shares@ US$84.9310.3% of flowClass A Common StockSEC:0002051759-26-000008:2
  • ▼
    Chief Operating OfficerExecutivesGeneDx Holdings Corp.
    53,796 USD27SEC
    623 shares@ US$86.356.3% of flowClass A Common StockSEC:0002051759-26-000008:3
  • ▼
    Chief Operating OfficerExecutivesGeneDx Holdings Corp.
    137,802 USD28SEC
    1,572 shares@ US$87.6616.2% of flowClass A Common StockSEC:0002051759-26-000008:4
  • ▼
    Chief Operating OfficerExecutivesGeneDx Holdings Corp.
    29,080 USD26SEC
    328 shares@ US$88.663.4% of flowClass A Common StockSEC:0002051759-26-000008:5
  • ▼
    Chief Operating OfficerExecutivesGeneDx Holdings Corp.
    9,045 USD26SEC
    100 shares@ US$90.451.1% of flowClass A Common StockSEC:0002051759-26-000008:6
  • ▼
    Chief Operating OfficerExecutivesGeneDx Holdings Corp.
    9,192 USD26SEC
    100 shares@ US$91.921.1% of flowClass A Common StockSEC:0002051759-26-000008:7
  • ▼
    Chief Operating OfficerExecutivesGeneDx Holdings Corp.
    64,684 USD19SEC
    779 shares@ US$83.0352100.0% of flowClass A Common StockSEC:0002051759-26-000008:0
  • ▼
    Chief Operating OfficerExecutivesGeneDx Holdings Corp.
    9,000 USD26SEC
    93 shares@ US$96.771.1% of flowClass A Common StockSEC:0002051759-26-000005:1
  • ▼
    Chief Operating OfficerExecutivesGeneDx Holdings Corp.
    48,516 USD27SEC
    492 shares@ US$98.615.7% of flowClass A Common StockSEC:0002051759-26-000005:2
  • ▼
    Chief Operating OfficerExecutivesGeneDx Holdings Corp.
    165,203 USD28SEC
    1,662 shares@ US$99.4019.4% of flowClass A Common StockSEC:0002051759-26-000005:3
  • ▼
    Chief Operating OfficerExecutivesGeneDx Holdings Corp.
    116,961 USD27SEC
    1,166 shares@ US$100.3113.7% of flowClass A Common StockSEC:0002051759-26-000005:4
  • ◇
    Chief Operating OfficerExecutivesGeneDx Holdings Corp.
    0SEC
    9,374 shares0Class A Common StockSEC:0002051759-26-000005:0

13 of 13 declarations